Klerimed

Clarithromycin, the active ingredient in Klerimed, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, skin and soft‑tissue infections, and is used in Helicobacter pylori eradication regimens as prescribed by a healthcare professional.

GNH USA supplies Klerimed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable delivery across global markets.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections of the respiratory and skin systems.

- Community‑acquired pneumonia: eliminates the causative bacteria and improves lung function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbations of chronic bronchitis: controls bacterial overgrowth and eases respiratory symptoms. - Skin and soft‑tissue infections: eradicates pathogenic bacteria and promotes wound healing. - Helicobacter pylori eradication regimens: contributes to bacterial clearance as part of combination therapy.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be watery. - Abdominal discomfort: cramping or pain in the abdomen. - Altered taste: metallic or bitter sensation.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rapid onset of hives, swelling, or breathing difficulty. - QT interval prolongation: may lead to cardiac arrhythmias. - Clostridioides difficile‑associated colitis: severe diarrhea with abdominal pain.

Before prescribing clarithromycin, clinicians should consider several safety factors.

- Assess liver function: clarithromycin is metabolized hepatically. - Monitor cardiac rhythm: avoid in patients with known QT prolongation. - Use cautiously in renal impairment: dose adjustment may be required. - Avoid in individuals with known macrolide hypersensitivity. - Review concomitant medications for potential interactions. - Store at below 25°C: keep in the original pack, protect from moisture.

Clarithromycin interacts with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - Drugs that prolong QT interval (e.g., quinidine, cisapride). - Simvastatin and other CYP3A4 substrates with narrow therapeutic windows. - Pimozide: risk of severe cardiac effects.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - Oral contraceptives: may reduce contraceptive effectiveness.